Difference between revisions of "Sickle cell vasoocclusion and rescue in a microfluidic device"

From Soft-Matter
Jump to: navigation, search
(Introduction)
Line 1: Line 1:
 
''by Professor Mahadevan''
 
''by Professor Mahadevan''
  
==Introduction==
+
==Abstract==
 
[[Image:Sickle_cell.jpg|260px|thumb|right|Sickle-cell]]  
 
[[Image:Sickle_cell.jpg|260px|thumb|right|Sickle-cell]]  
The pathophysiology of sickle cell disease is complicated by the multiscale processes that link the molecular genotype to the organismal phenotype: hemoglobin polymerization occurring in
+
I find this article particularly interesting although it is not directly related to capillarity and wetting. I enjoyed the authencity and creativity of the authors in designing the set of experiments to carry out their research. Most importantly, this article interested me is because the disease or scientific phenomenon studied is a rare but has significant impact on human society. As an introduction, sickle cell disease, the first molecular disease to be identified more than a half century ago, has been studied extensively at the molecular, cellular, and organismal level. The pathophysiology of sickle cell disease is complicated by the multiscale processes that link the molecular genotype to the organismal phenotype: hemoglobin polymerization occurring in milliseconds, microscopic cellular sickling in a few seconds or less, and macroscopic vessel occlusion over a time scale of minutes, the last of which is necessary for a crisis. Using a minimal but robust artificial microfluidic environment, the authors shows that it is possible to evoke, control, and inhibit the collective vasoocclusive or jamming event in sickle cell disease. Moreover, the authors also shows that a key source of the heterogeneity in occlusion arises from the slow collective jamming of a confined, flowing suspension of soft cells that change their morphology and rheology relatively quickly.
milliseconds, microscopic cellular sickling in a few seconds or less, and macroscopic vessel occlusion over a time scale of minutes, the last of which is necessary for a crisis. Using a minimal but robust artificial microfluidic environment, it can ben shown that it is possible to evoke, control, and inhibit the collective vasoocclusive or jamming event in sickle cell disease. It has been shown that a key source of the heterogeneity in occlusion arises from the slow collective jamming of a confined, flowing suspension of soft cells that change their morphology and rheology relatively quickly.
+
 
+
Sickle cell disease, the first molecular disease to be identified more than a half century ago, has been studied extensively at the molecular, cellular, and organismal level. On the one
+
hand, much is known separately about the molecular details of sickle hemoglobin polymerization, sickle cell deformability and its effects on flow, and the clinical heterogeneity of sickle cell disease. On the other hand, even though it is perhaps the simplest example of how a physicochemical process at the molecular level leads to pathology at the organismal level, integrating these processes presents a challenge at the intersection of medicine, biology, chemistry, and physics.
+
  
 
==Experimental Set-up==
 
==Experimental Set-up==

Revision as of 04:59, 28 April 2009

by Professor Mahadevan

Abstract

Sickle-cell

I find this article particularly interesting although it is not directly related to capillarity and wetting. I enjoyed the authencity and creativity of the authors in designing the set of experiments to carry out their research. Most importantly, this article interested me is because the disease or scientific phenomenon studied is a rare but has significant impact on human society. As an introduction, sickle cell disease, the first molecular disease to be identified more than a half century ago, has been studied extensively at the molecular, cellular, and organismal level. The pathophysiology of sickle cell disease is complicated by the multiscale processes that link the molecular genotype to the organismal phenotype: hemoglobin polymerization occurring in milliseconds, microscopic cellular sickling in a few seconds or less, and macroscopic vessel occlusion over a time scale of minutes, the last of which is necessary for a crisis. Using a minimal but robust artificial microfluidic environment, the authors shows that it is possible to evoke, control, and inhibit the collective vasoocclusive or jamming event in sickle cell disease. Moreover, the authors also shows that a key source of the heterogeneity in occlusion arises from the slow collective jamming of a confined, flowing suspension of soft cells that change their morphology and rheology relatively quickly.

Experimental Set-up

Fabrication and schematic of the device. The oxygen channels and vascular network were fabricated in separate steps, bonded via oxygen plasma activation, and attached to a glass slide. The widest crosssection in the vascular network on the left and right of the device is 4 mm * 12 um. The vascular network then bifurcates, maintaining a roughly equal total cross-sectional area. The gas channels were connected to two rotameters regulating the gas mixture that was fed into the device. The outlet of the gas network had an oxygen sensor to validate the oxygen concentration in the microchannels.

Experimental Set-up

The assembled microfluidic device was mounted on an inverted microscope, and the fluidic and gas sources were connected as shown in picture above. The microfluidic channels begin 4 mm wide, then split into roughly equal total cross-section areas until the smallest dimension, which then traverses 4 cm until the channels recombine sequentially at the outlet. The blood velocity was monitored most often in the 250-um channels, which were fed by four 60-um, eight 30-um, sixteen 15-um, or sixteen 7-um channels, depending on the device studied. Two rotameters controlled the gas mixture fed through the oxygen channels. The gas mixture diffused rapidly through PDMS to initiate occlusion or flow. The outlet gas concentration was monitored with a fluorescent oxygen probe to monitor the gas concentrations within the gas microchannels. Gravity-driven flow was used to inject blood into the vascular network and resulted inflowrates of up to 500um/sec. Researchers performed more than 100 different such occlusion assays, capturing more than 1,000 videos with �100,000 total frames. Given a device with a particular minimal width, researchers flowed a patient blood specimen with a known HbS fraction and a known red blood cell concentration. The pressure difference is modulated by changing the height of the pressure head and the gas concentration in the fluid channel is also modulated by adjusting the gas mixture flowing through the adjacent gas channels. Videos were captured at intervals.

Findings

Researchers find that oxygen diffuses through the experimental device over time scales on the order of 10 sec (roughly 10 times faster than occlusion and rescue events, which occur over time scales on the order of 100 sec). The oxygen concentration within the vascular network was quantified through bonding the microfluidic network to a glass slide coated with a ruthenium complex that fluoresces under 460-nm excitation and is quenched by oxygen. The intensity of the fluorescence can be correlated to the oxygen concentration by using the Stern–Volmer equation. It is important to consider the relative rates of ambient deoxygenation and hemoglobin oxygen unloading, especially when the collective chemical polymerization and collective hydrodynamics can act in concert. It is expected that the diffusion times for water-filled fluid channels in the control experiment to be similar to those for blood-filled channels because the fluid channel itself is 12 um high and represents only 10% of the total diffusion distance, which includes a 100-um-thick PDMS membrane between the gas and fluid channels. The velocity profile measurements begin with measurable changes in velocity that will occur when intracellular oxygen concentration drops below 3% or rises above 1%. Very rapid polymerization will occur when this concentration is below 1–2%.


Result

Fig. 1
Fig. 2
Fig. 3

Because vasoocclusion fundamentally represents the inability of the blood to flow, researchers measured the local velocity of the red blood cells in a microfluidic device with a selected minimal channel width. They controlled the pressure difference driving the steady flow of blood using a constant hydrostatic head, and determined the time for occlusion as a function of ambient oxygen concentration. This experiment allows researchers to characterize the phase space of occlusion or jamming using three coordinates: the minimum channel width in the microfluidic device, the total hydrostatic pressure difference across the device, and the ambient oxygen concentration. Fig. 1 shows a phase diagram where the volume between the coordinate planes and the curved surface shown defines the parameter space where occlusive events would be expected to occur within 10 min. Similar approximately-parallel isosurfaces define the boundary of differing temporal thresholds for occlusion. For unaffected individuals with 100% hemoglobin A (HbA), all fixed-time isosurfaces are located very close to the origin because the time to occlusion becomes very large almost regardless of pressure, oxygen, and vessel width.

Fig. 2 shows that rescue occurs over a much shorter time scale than occlusion. This dynamical asymmetry or hysteresis between occlusion and rescue events is a robust result that occurs in more than 95% of the experiments. The evolution of the vasoocclusive event was highly stochastic with large variations about the mean time for jamming under a fixed set of control parameters. This heterogeneity could arise from at least two sources: the highly cooperative nature of the HbS polymerization reaction whose onset is very slow relative to the subsequent explosive growth and the hydrodynamics of highly concentrated suspensions that are well known to jam. Researchers quantified the degree of hysteresis between the occlusion and rescue events by calculating the ratio between the characteristic time to occlusion and the characteristic time to relaxation, defined as the time required to reach half of the maximum velocity. Fig. 3 shows that, as the size of the minimal channel width increases beyond the red blood cell diameter of approximately 7 um, there is a significant increase in the variability of this ratio. In the devices with minimal channel width comparable to the size of a red blood cell, the ratio of the characteristic time to occlusion to that for rescue is more consistent across experiments. The effect of a sudden decrease in deformability caused by deoxygenation and polymerization alone is not sufficient to initiate an occlusive event in all but the narrowest channels; in addition, one needs multiple cells to form a stiff percolating network across the channel before there is a significant reduction in the velocity of the blood leading to vasoocclusion and self-filtration of the plasma. The large variability in the characteristic occlusion times in larger channels, as seen in Fig. 3, is a signature of the stochastic nature of the percolating process. Whereas jamming is a collective event, unjamming is not, because oxygen diffuses rapidly through the channels so that the intracellular HbS fibers depolymerize, making the cells more deformable fairly quickly, and flow starts.